Novartis Institutes For Biomedical Research President Mark Fishman: An Interview With “The Pink Sheet” DAILY (Part 1 of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
Head of firm’s research arm discusses Novartis’ drug discovery model, a growing pipeline of biologics and the company’s partnering strategy.
You may also be interested in...
Novartis Institutes For Biomedical Research President Mark Fishman: An Interview With “The Pink Sheet” DAILY (Part 2 of 2)
Fishman discusses his take on how metabolic drug development will change in the future, challenges in developing RNAi-based treatments and the role of federally funded research in innovation.
Novartis Institutes For Biomedical Research President Mark Fishman: An Interview With “The Pink Sheet” DAILY (Part 2 of 2)
Fishman discusses his take on how metabolic drug development will change in the future, challenges in developing RNAi-based treatments and the role of federally funded research in innovation.
Novartis Shanghai R&D Center To Focus On Diseases Prevalent In China
Establishment of the R&D site reflects Novartis’ commitment to the region, according to the drug maker.